Investing Smart: Bristol-Myers Squibb (BMY) Among the Best Affordable Dividend Stocks

Core Insights - Bristol-Myers Squibb Company (NYSE:BMY) is recognized as one of the 11 Best Affordable Dividend Stocks to buy now [1] - The company has demonstrated strong sales growth in its portfolio, with at least seven products achieving over 20% sales increases, including Breyanzi, which has more than doubled its sales [2] - The new schizophrenia treatment, Cobenfy, is projected to generate sales of $2.6 billion by 2030 following its FDA approval [3] Financial Performance - For the current year, Bristol-Myers Squibb expects earnings per share to be between $6.35 and $6.65, significantly exceeding its dividend commitment of $2.48 per share annually [4] - The company has a consistent history of raising dividends for 16 consecutive years, currently paying a quarterly dividend of $0.62, resulting in a dividend yield of 5.39% as of October 2 [5] Future Outlook - The strong lineup of new products is anticipated to offset losses from upcoming patent expirations, suggesting that the high-yield dividend could continue to grow for at least another decade [4]